IB
Iovance Biotherapeutics Inc
🇩🇪XFRA.2LBGermanyHealthcare
€8.09EURup +0.75 (+10.22%)OpenEnd of day7:29 PM
Price€8.09+0.75 (+10.22%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US4622601007
- CUSIP
- Not reported
Company
- Employees
- 975
- Headquarters
- San Carlos, United States
- Website
- https://www.iovance.com
- CEO
- Dr. Frederick G. Vogt Esq., J.D., Ph.D.
Market
- Shares outstanding
- 397M
- Market cap
- €3.21B
Highlights
- Market cap
- €3.21B
- EPS LTM
- -$0.73calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $324.97M+34.55%up year on year
- Net income
- -$289.52M+25.75%up year on year
- Gross margin
- 116.3%+464.57%up year on year
- Free cash flow
- -$296.4M+8.39%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.